Contineum Therapeutics, Inc. Class A Common Stock (CTNM) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for CTNM. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 99 institutions reported holding CTNM, with 30.5 million shares worth $500.6 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Suvretta Capital Management | 2,841,334 | $47M | UNCHANGED |
| Jupiter Topco | 2,734,836 | $45M | NEW |
| BlackRock | 2,064,345 | $34M | INCREASED |
| Johnson & Johnson | 1,979,173 | $32M | UNCHANGED |
| Franklin Resources | 1,839,227 | $30M | UNCHANGED |
Full institutional holdings, insider history, and congressional trades for Contineum Therapeutics, Inc. Class A Common Stock on SentiSense.